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Summary 
The MHC dass II-associated invariant chain (Ii) is involved in the intracdlular sorting of class 
II molecules to the endocytic pathway where peptides from processed exogenous antigens are 
bound, and thereby Ii is thought to enhance antigen presentation. Here we demonstrate that 
presentation of only one out of five epitopes of a given antigen is augmented by Ii. We have 
compared the presentation of five different epitopes derived from hen egg white lysozyme (HEL) 
to Ak-restricted  T  hybridomas by rat-2 fibroblasts  transfected  with A~  k and A~' (RKK)  and 
RKK cells supertransfected with the mouse invariant chain (RKKI). Only the presentation of 
the HEL epitope 46-61 was enhanced whereas the presentation of the HEL epitopes 25-43, 34- 
45, 112-124, and 116-129 was unchanged or even slightly diminished in RKKI cells. The presentation 
of the epitopes 25-43 and 34-45 was virtually insensitive to the lysosomotropic reagent chloroquine. 
Brefeldin A (BFA), which inhibits protein egress from the endoplasmic reticulum, blocked the 
presentation of all epitopes tested in RKKI cells. In contrast, in Ii-negative RKK cells only the 
presentation of the epitope HEL(46-61) was inhibited by BFA and the presentation of the epitopes 
25-43 and 34-45 was only slightly impaired. These findings suggest that Ii may target class II 
molecules to selected endosomal subcompartments involved in the processing of different peptides 
derived from an endocytosed antigen. As a result, the enhancement of the class II-restricted 
presentation in Ii expressing cells appears to be epitope specific rather than antigen specific. 
eT~he MHC  class II-associated invariant chain has been 
.L  ascribed a number of different functions. One proposed 
role is to provide a sorting signal for the intracellular trans- 
port ofdass II molecules (1). In HeLa ceils, transport of class 
II molecules to the endocytic compartment was observed only 
when Ii was coexpressed  (2, 3).  Ii probably directs dass II 
molecules to a late endosomal compartment (4). A second 
role has been suggested by biochemical studies indicating that 
Ii can block the peptide binding to dass II o~ dimers (5, 
6). Thus, Ii may prevent peptide loading onto class II mole- 
cules in preendosomal compartments. A third possible role 
of Ii is to act as a chaperone in the assembly and folding of 
dass II molecules, and in their egress from the endoplasmic 
reticulum (7, 8). 
These proposed functions suggest that Ii may facilitate the 
class II-restricted presentation of exogenous antigens to T 
cells. For Ltk-  cells transfected with mouse class II genes 
in the presence or absence of Ii, Ii expression was reported 
to enhance the presentation of some antigens like the com- 
plement component C5 (9),  hen egg lysozyme or measles 
virus hemagglutinin (10), but not of other antigens like oval- 
bumin or pork insulin (11). The crucial role of Ii in the pre- 
sentation of certain antigens was further demonstrated with 
splenocytes from mice lacking the Ii gene (12). Recently, it 
was shown that the alternatively spliced Ii gene product p41 
plays a role in the enhanced presentation of some antigens 
(13). Utilizing rat-2 fibroblasts expressing A k in the presence 
or absence of Ii, we previously reported that presentation of 
HEL but not of ribonuclease A  (RNase) was enhanced in 
the presence ofli (14). Extending these findings we now show 
that the facilitating function of Ii is restricted to only one 
out of five epitopes derived from processing of HEL, sug- 
gesting that Ii may be involved in the fine tuning of the im- 
mune response to exogenous antigens. 
Materials and Methods 
Transfectants.  Rat-2 fibroblasts transfected with cDNA con- 
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scribed (14). Supertransfection with genomic DNA coding for mu- 
fine Ii was  performed as described (14).  RKKI done 4  which 
expresses high amounts of Ii was used in this study. Ii expression 
was determined by cytoplasmic immunoperoxidase staining and by 
immunoprecipitation. The T cell hybridomas 2B6,31 (15), 1C5.1, 
2D4.1 (16), 3A9 (17), 2C8.4 (18), and TS1.2  (19) have been de- 
scribed. The T cell hybridomas 3Bl1.1,  4G4.1, 1G5.1, 2B5.1, and 
1B9.1 were generated for the present study and characterized as 
described  (18). 
lraraunoprecipitations.  Immunoprecipitations were performed as 
described (14). Briefly, 3  x  106 cells were labeled for 1 h with 100 
/~Ci of a mixture of 80% [35S]methionine and [35S]cysteine  (ICN- 
Flow, Cleveland, OH). The adherent ceils were harvested from the 
dishes  with TBS lysis buffer containing 1% NP-40.  The lysates 
were precleared with Protein A-soluble  (Sigma Chemical Co., St. 
Louis, MO) and a mixture of normal rat and mouse sera. For im- 
munoprecipitations, Protein A-Sepharose beads (Pharmacia,  Inc., 
Piscataway, NJ) preabsorbed with monoclonal antibodies were added 
to the lysates for 2 h. A  k molecules were precipitated with mAb 
Hl16-32. To precipitate Ii, mAb In1 was used together with the 
protein A binding anti-rat kappa  chain antibody MAR18.5  (for 
references see 13). The immunoprecipitates were analyzed on 12% 
SDS-PAGE. 
Cytofluorometry,  Peptide Binding Assay.  Surface immunofluores- 
cence staining  for A  k was  performed with  mAb  Hl16-32  and 
FITC-conjugated goat anti-mouse Ig (GIBCO-BRL Life Technols, 
Inc., Gaithersburg, MD). For intracelhlar staining of Ii, cells were 
permeabilized with 0.3% saponin (Sigma Chemical Co.) and stained 
with  mAb  In1  followed by FITC-conjugated goat  anti-rat  Ig 
(Southern Biotechnology, Inc., Birmingham,  AL). 
Peptide binding to cell surface A  k molecules was measured es- 
sentiaUy as described (20). RKK and RKKI ceils were mixed with 
varying concentrations of biotinylated HEL peptide 46-61 and in- 
cubated at 37~  for 3.5 h. Subsequently the cells were stained with 
successive  layers  of fluoresceinated  avidin  D,  biotinylated  goat 
anti-avidin D antibody, and again fluoresceinated avidin D (Vector 
Labs, Inc., Burlingame, CA). Staining was at 4~  for at least 30 
min per layer followed by two washes. Class II expression was de- 
termined in the same experiment using saturating amounts of  FITC- 
conjugated mAb Hl16-32. 5000 cells per sample were analyzed for 
median fluorescence channel (MFC) intensity on a FACScan flow 
cytometer (Becton Dickinson and Co., Mountain View, CA). After 
background subtraction, the effects of variations in A k expression 
between cells was  eliminated by calculating MFC ratios  [(MFC 
with peptide -  MFC without peptide)/(MFC with H116-32-FITC 
-  MFC with control Ab)]. 
Cell Cultures.  Antigen presentation assays were performed as 
described (13,  14).  Briefly,  cultures  containing  2.5  x  104 pre- 
senting calls and 5  x  104 T  hybridoma cells were set up in mi- 
crotiter plates  with antigen in 200/~1 RPMI 1640 supplemented 
with 10% FCS. After 24 h of culture, 50/~1 of supernatants were 
assayed for the presence of IL-2 by culture with 104 CTLD2 cells 
for 24 h. During the final 4 h of culture, the CTLL-2 cells were 
pulsed  with  1  /~Ci [3H]-methyl-thyraidine  (Amersham  Intl., 
Buckinghamshire, England). Each point in the graphs of Figs. 2-4 
represent the mean from triplicate cultures. 
RKK and RKKI cells were preincubated with graded doses of 
chloroquine (Sigma Chemical Co.) for 30 min or with brefeldin 
A  (BFA) (Sandoz)  for 15 min in complete medium followed by 
the addition of antigen for 4 h as described (19). Subsequently, the 
ceils were fixed in 0.05% glutaraldehyde for 30 s on ice, quenched 
in 0.2 M glycine, and washed three times before T hybridoma cells 
were added. 
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Results and Discussion 
The influence of Ii on the presentation of helper epitopes 
derived  from  HEL  was  studied  using  Ak-transfected  Ii- 
negative rat-2 fibroblasts (RKK), or RKK ceils supertrans- 
fected with genomic DNA coding for mouse Ii (RKKI).  In 
RKKI cells a high level of Ii expression in excess of A k mol- 
ecuhs was  shown by sequential immunoprecipitation  with 
monodonal antibodies against A k and Ii (Fig.  1 a). The ex- 
pression of Ii in RKKI ceUs was homogenous as determined 
by intraceilular cytofluorometry (Fig.  1 b). The level of A k 
cell surface expression was slightly lower in the RKKI done 
used in this study than in RKK parental cells (Fig. 1 b), pos- 
sibly due to intrinsic clonal variability of these ceils. Although 
Ii is supposed to facilitate the egress of class II molecules from 
Figure  1.  (a) Immunoprecipitation  of A  k and Ii molecules  from meta- 
bolically labded RKK and RKKI ceils. For control, untransfected rat-2 
cells (R) were used. First A  k was precipitated with mAb Hl16-32 (anti-1- 
Ak), then Ii was precipitated from the same lysates with mAb In1 (anti- 
I  0. The positions of the o~ and B chains of A  k and of the p31 form of 
li are indicated. Ii coprecipitates  with A  k in RKKI cells but is absent in 
RKK cells. As visible for the B chain of A  i, class II molecules  are more 
rapidly  processed  into higher glycosyhted  forms in the presence  of  Ii. After 
cleating of  class II molecules,  high amounts of  free Ii were recovered  from 
RKKI cells. (b) Surface  immunofluorescence  staining of RKK and RKKI 
cells for Ak with mAb Hl16-32. Ii was intracelhlarly stained with mAb 
Inl after  permeabilization  of  cells with saponin. (c) Indistinguishable  binding 
of biotinylated peptide HEL(46-61)  to RKK and RKKI cells. Cells were 
incubated with graded amounts of  biotinyl-HEL(46-61)  and stained with 
two layers  of avidin-FITC  sandwiched  by biotinylated anti-avidin  Ab. The 
MFC ratios shown represent  rehtive peptide  binding, normalized  f~r differ- 
ences in class II expression  that were determined in the same experiment 
(see Materials and Methods). 
Invariant Chain Enhances Presentation of Specific  Epitopes Table  1.  Activation of A~-restricted T  Cell Hybridoraas by Ii-negative RKK Cells and by Ii-positive RKKI Cells 
ECso for protein (gM)  ECs0 for peptide (gM) 
ratio ECs0 
Hybridoma  Peptide  Restriction  RKK  RKKI  RKK/RKKI  RICK  RKKI 
2B6.31  HEL 25-43  A  ~  220  270  0.82  5.00  13.00 
3Bl1.1  HEL 34-45  A  k  60  100  0.60  3.00  6.00 
1C5.1  HEL 46-61  A  k  150  2  75.00  0.05  0.13 
4(34.1  HEL 46-61  A  k  45  12  3.75  0.50  1.10 
1G5.1  HEL 46-61  A  k  170  40  4.25  0.04  0.05 
2B5.1  HEL 46-61  A  k  200  7  28.57  0.30  0.80 
3A9  HEL 46-61  A  k  100  3  33.33  0.50  0.80 
2D4.1  HEL 112-124  A  k  500  600  0.83  0.10  0.40 
2C8.4  HEL 116-129  A  k  500  500  1.00  0.13  0.50 
1B9.1  HEL 116-129  A  k  150  300  0.50  0.07  0.30 
TS1.2  RNase 43-56  A  k  0.5  2  0.25  1.50  2.00 
The responsiveness of T cell hybridomas  to protein antigen (HEL  or RNase)  or to the indicated synthetic  peptide presented by RKK or ILKKI 
cells was estimated by the antigen concentration (/~M) giving 50% of the maximal response (ECs0). A representative experiment out of three per- 
formed with similar results  is shown. 
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the endoplasmic reticulum we have observed similar levels 
of surface class II on a large variety of class II transfectants 
such as rat-2, HeLa, and RMA cells in the absence and pres- 
ence of Ii. This is in contrast to splenocytes from Ii knock- 
out mice, which express only low levels of class II on the 
cell surface (12). The reason for this discrepancy is not clear. 
In any case, when differences in I-A  k expression were taken 
into account, the relative ability of surface class II molecules 
to bind peptides was similar in RKK and RKKI cells (Fig. 1 c). 
10 T ceU hybridomas with specificity for five Ak-restricted 
HEL epitopes were used to study the effect of Ii on the pre- 
sentation of individual epitopes. In Table 1,  a quantitative 
evaluation of the response curves is given. The ratio of the 
antigen concentrations yidding 50% of the maximal responses 
(ECs0) for RICK vs. RKKI cells was greater than 3.0 for all 
five T  cell hybridomas recognizing the HEL peptide 46-61, 
namely 1C5.1, 4G4.1, 1G5.1,  2B5.1, and 3A9, indicating a 
dear enhancement of the presentation of this epitope in the 
presence of Ii. A  typical example is presented in Fig.  2 a. 
It can be seen that RKKI cells stimulated 3A9 T hybridoma 
Figure 2.  Efficiency  of the presentation of the Ak-restricted HEL epi- 
topes 46-61 and 25-43 by Ii-negative and Ii-positive rat-2 cells. RKK cells 
(ape, symbols)  or RKKI cells (closed symbols),  2.5  ￿  104/well, were in- 
cubated for 24 h with graded concentrations of HEL (squares) or the ap- 
propriate peptide (triangles) and 5  x  104/weU  T hybridoma cells. For con- 
trol fixed RKKI cells (circles) were incubated with HEL. In (a) hybridoma 
3A9 (HEL 46-61) and in (b) hybridoma RB6.31 (HEL 25-43) was used. 
II~2 production was  determined  by [3H]thymidine  incorporation into 
CTLL-2 cells. Data are presented as mean cpm from triplicate cultures. 
Brief Definitive Report cells at an about 30-fold lower HEL concentration than RKK 
cells, but that at high HEL concentrations RKK stimulated 
almost as well as RKKI. For the hybridomas 1C5.1, 2B5.1, 
and 3A9, the ECs0 ratios were about 10 to 20 times greater 
than for the hybridomas 4G4.1  and 1G5.1. This difference 
did not correlate with the sensitivity  of the hybridomas as 
determined by their responses to exogenously added peptide 
(Table 1). Exogenously added peptide was always presented 
somewhat more ei~ciently by RKK cells than by RKKI cells. 
This difference probably reflects the slightly higher level of 
A k expression in RKK because the degree of loading with 
peptide  was similar for both cell lines  (Fig.  1 c). The fine 
specificities of these hybridomas for shorter peptides within 
the sequence 46-61 have not been compared. Thus, it seems 
possible  that  the differences in the ECs0 ratios are due to 
differentially enhanced presentation of subdeterminants of epi- 
tope 46-61. 
Using the hybridomas 2B6.31 (Fig. 2 b) and 3Bl1.1 recog- 
nizing the overlapping HEL epitopes 25-43 and 34-45, respec- 
tively, an ECs0 ratio dose to unity was found indicating that 
Ii did not facilitate the presentation of these epitopes.  The 
hybridomas 2I)4.1, 2C8.4, and 1139.1 recognizing the over- 
lapping COOH-terminal epitopes HEL 112-124 and 116-129, 
respectively,  showed  ECs0 ratios <1.0  demonstrating  the 
lack of enhancement  for these epitopes by Ii. For compar- 
ison, the hybridoma TS1.2  specific for the gNase  epitope 
43-56 was included (Table 1). RKK cells were dearly supe- 
rior to RKKI cells in the presentation of RNAse (ECs0 ratio 
0.25). 
The lysosomotropic  reagent chloroquine interferes with 
the acidification of the endosomal compartment. For selected 
a 
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Figure  3.  Chloroquine sensitivity  of the presentation of HEL by RKK 
and RKKI cells. RKK cells (a) and ILKKI ceils (b), 2.5  x  104/well, were 
incubated 30 rain before and during a 4-h pulse with 1 mM HEL in the 
presence of g.ded doses of chloroquine. The presenting cells were fixed 
and 5  x  104/well T hybridoma cells, 2B6.31 (/x.ptide 25-43) (~7), 3Bl1.1 
(pq,ti& 34-45) (rl), 4c,4.1 (pq, ti& 46-61) (A), and m9.1 (p~ptide 116.129) 
(O), respectively, were added for 24 h. The control responses in the ab- 
sence of chloroquine were (a), 189263 clan (~7), 347265 cpm ([~), 300111 
cpm (A), 108263 (O),  and (b), 65958  (~7), 106663 ([]),  114726 (A), 
12581 (o). 
b 
% res )onse 
100-1 
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Figure  4.  Brefddin sensitivity of the presentation of HEL  by R.KK and 
RKKI calls. ILKK cells (a) and RKKI cells (b), 2.5  x  104/well,  were 
incubated 15 min before and during a 4-h pulse with 500/~M HEL in 
the presence of graded doses of BFA. The presenting cells were fixed and 
5  x  104/well T  hyhridoma ceils, 286.31  (V), 3Bl1.1  ([~), 4G4.1  (A), 
and 1G5.1 (O), respectively, were added for 24 h. The control responses 
in the absence of BFA were  (a),  166822 cpm (V),  180794 cpm (D), 
322707 cprn (A), 103109 (O),  and (b), 53502 (~7), 39600  ([~), 97765 
(A), 17434 (O). 
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sentation of HEL epitopes by RKK and RKKI cells (Fig. 
3). Interestingly, the presentation of the epitope 34-45 was 
not inhibited by titrated doses of chloroquine in RKK cells, 
and showed a slight inhibition only at 300 gM in RKKI cells. 
Similarly, increasing doses of chloroquine had little effect on 
the presentation of epitope 25-43.  In contrast, chloroquine 
clearly inhibited the presentation of the epitopes 46-61 and 
116-129 in both RKK and RKKI cells. For the four epitopes 
studied, presentation by RKKI cells was always somewhat 
more sensitive to chloroquine than presentation by RKK cells 
(see Fig. 3 b). This is in agreement with the observation that 
chloroquine inhibits the proteolytic removal of Ii from dass 
II oe3 dimers before their transport to the cell surface (21). 
The fungal metabolite brefeldin A blocks the vesicular trans- 
port from the endoplasmic reticulum. In addition, BFA was 
reported to induce the fusion of early endosomes with the 
trans-Golr~ network (22). However, the extent of impairment 
induced by BFA on the transport and the degradation of en- 
docytosed proteins is controversial (22, 23). We have studied 
the effect of BFA on the presentation of the HEL epitopes 
25-43, 34-45, and 46-61 (Fig. 4). When RKK cells were used 
as APC, the presentation of the epitopes 25-43  and 34-45 
was inhibited by only 30-40% even at the highest BFA doses 
used, whereas the presentation of epitope 46-61 was almost 
completely blocked. In a previous study presentation of epi- 
tope 116-129 by LK-35.2 B cells was also inhibited by BFA 
(24).  In RKKI cells, the presentation of the three epitopes 
tested was clearly inhibited by high doses of BFA, although 
the presentation of epitopes 25-43 and 34-45 was inhibited 
to a lesser extent at concentrations lower than 30/~M BFA. 
Out of the five Ak-restricted  HEL epitopes studied here, 
only the presentation of the epitope 46-61 was enhanced in 
the presence of an invariant chain. This may indicate that 
the  Ii-mediated targeting of the class II/Ii complex to  a 
prelysosomal compartment (4) is responsible for the selective 
enhancement in the presentation of HEL(46-61).  The pre- 
sentation of this epitope, and of 116-129, was clearly more 
sensitive to chloroquine than the epitopes 25-43 and 34-45. 
In line with these results are observations showing that the 
chloroquine-sensitive environment of lysosomes is required 
for the initial reduction of disulfide bonds in HEL, and sub- 
sequent presentation of the epitope 46-61 (25, 26). The HEL 
epitopes 34-45 and 25-43 are virtually insensitive to chloro- 
quine, suggesting  processing in early endocytic compartments, 
where protein breakdown may be less dependent on acidic 
pH, or processing by endoproteinases relatively resistant  to 
increased pH. 
Alternatively,  the loading of peptides onto class II mole- 
cules, rather than their deavage, could be differentially  in- 
fluenced by chloroquine. This would be consistent with the 
observation that the binding of peptide 34-45  to fixed A k- 
expressing cells is unchanged between pH 5.0 to pH 7.4, 
whereas the binding of peptide 46-61 shows an optimum at 
pH 5.5 (27). Utilizing purified A k molecules, Sette et al., 
found a binding optimum for HEL(46-61)  at pH 4.5 (28). 
In  RKK  cells, the  presentation of peptide 46-61  was 
significantly more sensitive to BFA treatment than the pre- 
sentation of the peptides 25-43 and 34-45. In line with previous 
observations (24, 29) this may imply that the peptide 46-61 
binds  to  A k in  an  endosomal subcompartment fed  with 
newly synthesized class II molecules which are retained in 
the ER in the presence of BFA. In contrast, the peptides 25- 
43 and 34-45  seem to have access to a pool of preexisting 
class II molecules that may arise from internalization of un- 
loaded molecules from the surface. In RKKI cells the presen- 
tation of the three HEL peptides, 25-43,  34-45,  and 46-61, 
was dearly sensitive to BFA, indicating presentation by newly 
synthesized class II molecules. 
In conclusion, it appears that the augmenting effect of Ii 
is actually epitope specific rather than simply antigen specific 
(9, 10, 14). In addition, distinct pathways of presentation for 
different HEL epitopes exist. The epitope 46-61 is exclusively 
or predominantly bound by newly synthesized class II mole- 
cules  and its presentation is highly chloroquine sensitive, 
whereas in the absence of Ii the epitopes 25-43  and 34-45 
can be presented by a pool of preexisting class II or, in the 
presence of Ii, also by newly synthesized class II molecules. 
The precise rules controlling preferential presentation of par- 
ticular epitopes from the same protein antigen by different 
pathways remain to be explored. 
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